Aniket Ratikant Aligave

Aniket Ratikant Aligave

Active Director Director DIN 07542842
DIN 07542842 First appointment Jul 2016 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Aniket Ratikant Aligave

Data last updated:

Aniket Ratikant Aligave is a Director at Vigikon Pharmatech Private Limited (since 2016). The company operates in Business Services.

DIN 07542842
Primary Designation Director
Industry Business Services
First Appointment 20 Jul 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vigikon Pharmatech Private Limited U74999PN2016PTC165608
Director20 Jul 20162016Active

Board colleagues of Aniket Ratikant Aligave

NameDINCompanyDesignation
Ajit Ramrao Patil07545932Vigikon Pharmatech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Vigikon Pharmatech Private Limited
Premium access

Shareholding and investment profile for Aniket Ratikant Aligave

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aniket Ratikant Aligave

Aniket Ratikant Aligave currently holds 1 directorship: Vigikon Pharmatech Private Limited (Director, since 20 Jul 2016).

Aniket Ratikant Aligave was first appointed on 20 Jul 2016 as Director at Vigikon Pharmatech Private Limited.

The current boards of Aniket Ratikant Aligave's companies include Ajit Ramrao Patil (Vigikon Pharmatech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available